Risk factors for acute pulmonary edema in preterm delivery

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 133, Issue 2, 2007, Pages 143-147

  Ogunyemi, Dotun ^a  

^a MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

Antenatal corticosteroid therapy; Chorioamnionitis; Preterm labor; Pulmonary edema; Tocolytic agents

Indexed keywords

MAGNESIUM SULFATE; NIFEDIPINE;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE CONTROL STUDY; CHORIOAMNIONITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG EDEMA; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; PREDICTION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMALL FOR DATE INFANT; SMOKING; TOCOLYSIS; UNIVARIATE ANALYSIS;

EID: 34447539759     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.09.001     Document Type: Article

References (13)

1. Sciscione A., Ivester T., Largoza M., Manley J., Shlossman P., and Colmorgen G.H.C. Acute pulmonary edema in pregnancy. Obstet Gynecol 101 (2003) 511-515
2. Poggi S.H., Barr S., Cannum R., et al. Risk factors for pulmonary edema in triplet pregnancies. J Perinatol 23 (2003) 462-465
3. Samol J.M., and Lambers D.S. Magnesium sulfate tocolysis and pulmonary edema: the drug or the vehicle?. Am J Obstet Gynecol 192 5 (2005) 1430-1432
4. Psiani R.J., and Rosenow III E.C. Pulmonary edema associated with tocolytic therapy. Ann Intern Med 110 9 (1989) 714-718
5. Elliott J.P., Istwan N.B., Rhea D., and Stanziano G. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy. Am J Obstet Gynecol 191 4 (2004) 1277-1282
6. Perry Jr. K.G., Morrison J.C., Rust O.A., Sullivan C.A., Martin R.W., and Naef III R.W. Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion. Am J Obstet Gynecol 173 4 (1995) 1273-1277
7. Masue T., Shimonaka H., Terazawa E., et al. Prediction of patients with higher order multifetal pregnancy at risk for postpartum pulmonary edema. Eur J Obstet Gynecol Reprod Biol 81 1 (1998) 33-36
8. Armson B.A., Samuels P., Miller F., Verbalis J., and Main E.K. Evaluation of maternal fluid dynamics during tocolytic therapy with ritodrine hydrochloride and magnesium sulfate. Am J Obstet Gynecol 167 3 (1992) 758-765
9. Cunningham F.G., Lucas M.J., and Hankins G.D. Pulmonary injury complicating antepartum pyelonephritis. Am J Obstet Gynecol 156 4 (1987) 797-807
10. Towers C.V., Kaminskas C.M., Garite T.J., Nageotte M.P., and Dorchester W. Pulmonary injury associated with antepartum pyelonephritis: can patients at risk be identified?. Am J Obstet Gynecol 164 4 (1991) 974-978 [discussion 978-980]
11. De Veciana M., Towers C.V., Major C.A., Lien J.M., and Toohey J.S. Pulmonary injury associated with appendicitis in pregnancy: who is at risk?. Am J Obstet Gynecol 171 4 (1994) 1008-1013
12. Hatjis C.G., and Swain M. Systemic tocolysis for premature labor is associated with an increased incidence of pulmonary edema in the presence of maternal infection. Am J Obstet Gynecol 159 3 (1988) 723-728
13. Yeast J.D., Halberstadt C., Meyer B.A., Cohen G.R., and Thorp J.A. The Risk of pulmonary edema and colloid osmotic pressure changes during magnesium sulfate infusion. Am J Obstet Gynecol 169 6 (1993) 1566-1571